We are the central laboratory for several clinical trials and observational studies, for which we provide comprehensive molecular diagnostics and pathology testing services.
Using our highly sensitive and specific proprietary panel of assays we perform the following analyses to screen for genetic alterations predictive of response or resistance to targeted therapies:
Mutation analysis in tumor tissue and blood
Gene amplification and translocation testing
Our Molecular Oncology Laboratory is fully staffed by a team of highly experienced molecular biologists and pathologists and equipped with state-of-the-art technology. Our streamlined sample reception and processing systems and proprietary data management software ensure efficient sample handling and communication with recruiting centers.
We offer an 8 working day turnaround on samples received and are able to process formalin-fixed paraffin-embedded tumor tissue, fresh frozen samples, serum, plasma, platelets, and cytologies.
We have served, or are currently serving, as the central laboratory for the following Phase III trials:
|EUCROSS||University of Cologne/Pfizer|
|NVALT15||Stichting NVALT Studies/SLCG|
We also have a Phase I-II Trial Unit and are able to perform pharmacokinetics studies in-house for patients recruited to phase I-II cancer trials open in the Dr. Rosell Oncology Institute (Quirón Dexeus University Hospital, Hospital Quirón Teknon and Sagrat Cor University Hospital, Barcelona, and the General de Catalunya University Hospital, Sant Cugat dels Vallès).
For further details of our clinical trial services: Contact us